Communication regarding fluoroquinolones
National authorities have been urged to enforce this ruling and to take all appropriate measures to promote the correct use of this class of antibiotics. It is vitally important that urologists are fully informed of the impact of this decision on their daily clinical practice.
Fluoroquinolones should not be used for the:
Prevention of recurrent urinary tract infections.
Prevention of infection after surgeries or interventions in the urogenital
system, including transurethral surgery or transrectal prostate biopsy
Treatment of sepsis
Other indications have been maintained e.g. treatment of complicated UTI and bacterial prostatitis; restricted; or reworded according to the current medical knowledge.
More information on this topic can be accessed via the European Medicines Agency website.